News und Analysen
Eilt: Hautkrebs vollständig geheilt - Großinvestoren unmittelbar vor Einstieg. Massives Kaufsignal. Neuer 159% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Großinvestoren unmittelbar vor Einstieg. Neuer 159% Biotech Hot Stock nach 6.960%
18.01.24 08:02
London (www.aktiencheck.de, Anzeige)
Oil is in contango for the first time since 2021: Best oil stocks
The days of open outcry commodity trading are nearly extinct, as most of today's trading takes place behind a desk and through online brokerages. However, the traders that ascended from these pits
MAX 9 may not affect Boeing's earnings; should you buy the dip?
Good traders ride the trend; they were the ones who came up with the saying, "The trend is your friend."
While they may successfully ride the waves in the big market movers, those who take on
3 downgraded names you can buy into
A downgrade isn't necessarily bad, just like an upgrade isn't always a reason to buy.
Sometimes, downgrades or downward revisions to price targets are a natural and healthy part of market
3 high yield stock ETFs that make any income portfolio better
When preparing a winning meal, careful selection of the right ingredients is paramount. The same can be said about building a winning investment portfolio.
Once a money-making strategy has been
Are CVS store closures prescription for better financial health?
After CVS Health Corp. (NYSE: CVS) said it would shutter dozens of pharmacies in Target Corp. (NYSE: TGT) stores, the stock immediately declined by 3%, but in the January 16 session was bucking
Medtronic receives FDA approval for deep brain stimulation system
Medtronic PLC (NYSE: MDT), a member of the medical sector and the healthcare industry, received U.S. FDA approval for its implantable medical device called the Percept PC Deep Brain Stimulation
UnitedHealth's rising premiums could cushion stubborn inflation
When markets become uncertain about the economy's direction and stocks trend in a bumpy and indecisive pattern, some sectors usually attract investment dollars because of their perceived safety.
Solo Brands cooked on 2023 guidance cut. Is it a bargain or trap?
Outdoor and lifestyle products maker Solo Brands Inc. (NASDAQ: DTC) has grown a cultlike following under its many brands. The consumer discretionary sector company initially started by offering an
Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. Neuer 133% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Großinvestoren vor Einstieg in diesen Biotech Hot Stock - Massives Kaufsignal. 133% Biotech Aktientip nach 15.973%
17.01.24 08:02
London (www.aktiencheck.de, Anzeige)
Time to buy these 3 healthcare companies that raised revenue guidance?
The new year brings a clean slate heading into the fourth-quarter earnings season. Companies can usually gauge if their previous forecasts were in line or need to be adjusted to warn or prepare
PayPal gearing up for a breakout despite shifting sentiment
Few names outperformed PayPal Holdings Inc. (NASDAQ: PYPL) during the COVID-19 pandemic. Imagine a company that not only weathered the storm of the COVID-19 pandemic but thrived amidst the chaos,
Power Plays: MSFT, NVDA, GOOGL, META dominate market moves
Last week, an interesting picture of triumph was painted in the stock market, with the technology sector taking the lead. Now, this may come as no surprise. The stars of the show were none other
Bitcoin ETFs: A two-day ranking of top performers
The recent approval and launch of eleven Bitcoin spot ETFs have added a thrilling chapter. Building up to the much-anticipated approval, the market was brimming with anticipation.
As the U.S.
Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. Neuer 152% Biotech Aktientip nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Einstieg Institutioneller Investoren voraus - Massives Kaufsignal. 152% Biotech Aktientip nach 134.452% mit Biogen
16.01.24
London (www.aktiencheck.de, Anzeige)
3 retailers to compound your wealth this cycle
Today's market is the epitome of opportunity for those who know where to look. Considering that most market analysts suggest the stock market is overvalued today, by measures such as the Buffett
Rising credit card delinquencies make these stocks your safer bet
The credit cycle, as well as the business cycle in the United States economy, is getting underway for a major pivot coming into 2024. Whether you are a long-term investor or enjoy dabbling in and
3 stocks to keep in mind as a Red Sea conflict emerges
Every cycle brings about its own set of surprises, ones that, by their very own definition, are quite unpredictable. Today, the market and investors, just like you, may have been accustomed to a
These 4 factors driving growth of young fintech stock Tradeweb
You know those stocks from arcane industries that don’t get all the attention of, say Apple Inc. (NASDAQ: AAPL), Microsoft Corp. (NASDAQ: MSFT) or Nvidia Corp. (NASDAQ: NVDA)?
Intel, Mobileye, Microchip see slowdown in automotive chip orders
When autonomous driving tech specialist Mobileye Global Inc. (NASDAQ: MBLY) got smacked down on January 4 on a surprise cut in its revenue forecast, it was signaling trouble throughout the
Eilt: Institutionelle Investoren unmittelbar vor Einstieg - Massives Kaufsignal. Neuer 156% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 156% mit Biotec
Eilt: Institutionelle Investoren unmittelbar vor Einstieg - Kaufsignal. 165% Biotech Hot Stock nach 15.973% mit BioNTech
15.01.24 08:03
London (www.aktiencheck.de , Anzeige)
UnitedHealth Group Looks Buyable After AI-Fueled Double Beat
The big banks will get the headlines, but investors should watch UnitedHealth Group Inc. (NYSE: UNH). The health insurance giant scored a double beat when it reported fourth-quarter earnings on
20% upside for JPMorgan Chase stock? Here’s how
Shares of JPMorgan Chase & Co. (NYSE: JPM) surged more than 5% immediately following the Q4 earnings release. The release aside, the move higher has extremely bullish implications for this market
Super Micro's super surge: 18.87% gain to begin the year
Super Micro Computer Inc. (NASDAQ: SMCI) started 2024 with a bang, rallying 18.87% in the past week.
The stock is in a buy zone, trading just below its January 10 high of $357.99.
The company's
Nvidia's skyrocketing journey into 2024
Last year’s hottest stock, Nvidia (NASDAQ: NVDA), has begun the new year the same way it ended its previous year. As you most likely know, shares of the chipmaker were up a staggering 239% in